The number of people with susceptibility test result for rifampicin in Japan
Japan: The number of people with susceptibility test result for rifampicin was 62.2 in 2021. ▼ Falling
Latest (2021)
62.2
Change on year
down 2.7%
World rank
108th
of 146 countries
All-time high
74.2
in 2018
All-time low
62.2
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Japan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Japan is 62.2, measured in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 2.7% on the previous year and down 13.1% over five years.
Japan ranks 108th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Japan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 71.58 | — |
| 2018 | 74.2 | +3.7% |
| 2019 | 69.75 | -6.0% |
| 2020 | 63.93 | -8.3% |
| 2021 | 62.2 | -2.7% |
Japan compared with similar countries
- Japan's 62.2 is below the median for high income countries, which is 92.6, 67% of the median. (56 countries reporting)
- Japan's 62.2 is below the median for East Asia & Pacific, which is 96.47, 64% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 71.84 | 69.75 | 74.2 | 3 |
| 2020s | 63.07 | 62.2 | 63.93 | 2 |
Countries ranked near Japan
- 105 Cape Verde 69.01 compare
- 106 Burkina Faso 67.26 compare
- 107 Kenya 63.13 compare
- 109 Croatia 60.19 compare
- 110 Trinidad and Tobago 59.38 compare
- 111 Côte d'Ivoire 59.19 compare
More health data for Japan
- Un projection of annual infant deaths, annual growth rate -2.73 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2774 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,294 deaths per 1,000 people (2090)
- Number of infants who die before age 1 178 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0155 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Japan?
- The number of people with susceptibility test result for rifampicin in Japan was 62.2 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Japan?
- The highest recorded value was 74.2 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Japan?
- The lowest recorded value was 62.2 in 2021.
- How does Japan rank for the number of people with susceptibility test result for rifampicin?
- Japan ranks 108th out of 146 countries with data for 2021.
- Where does this Japan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).